跳至主要内容
临床试验/NCT04902222
NCT04902222Unknown不适用

Incidence of Orthostatic Intolerance and Orthostatic Hypotension After Administration of Intravenous Morphine in Patients Prior to Hip or Knee Arthroplasty

Copenhagen University Hospital, Hvidovre1 个研究点 分布在 1 个国家目标入组 26 人开始时间: 2021年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
26
试验地点
1
主要终点
Incidence of orthostatic hypotension

研究概览

简要总结

Incidence of orthostatic intolerance and orthostatic hypotension after intravenous administration of morphine in patients prior to hip or knee arthroplasty.

详细描述

Early postoperative mobilization is crucial for recovery of patients undergoing surgery in the multimodal fast-track approach to perioperative care, since physical immobilization is highly associated with increased risk of postoperative complications and prolonged hospital length of stay. Postoperative mobilization is often delayed due to patients experiencing orthostatic hypotension (OH), defined as a drop in systolic blood pressure > 20 mmHg or diastolic blood pressure > 10 mmHg, or orthostatic intolerance (OI), characterized by dizziness, blurred vision, nausea, vomiting, sensation of heat or syncope.

Previous studies have found a high incidence of postoperative OI (> 40 %) among patients undergoing total hip arthroplasty.

A possible causative factor to the high occurrence of OH and OI after surgery could be postoperative pain management by administration of morphine. Morphine is known to have many side-effects including nausea, vomiting, dizziness and orthostatic hypotension.

The object of this study is to isolate and estimate the effect of intravenous morphine on the incidence of OH and OI.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing primary unilateral total hip arthroplasty (THA), total knee arthroplasty (TKA) or unicompartmental knee arthroplasty (UKA)
  • Patients > 18
  • Patients that understand and speak Danish
  • Patients that have provided written informed consent

排除标准

  • Alcohol or substance abuse
  • Habitual use of opioids
  • Habitual use of anxiolytic, antidepressant and/or antipsychotic drugs
  • History of previous orthostatic intolerance or hypotension
  • Cognitive dysfunction
  • Glomerular filtration rate (GFR) < 30 ml/min
  • Cardiac arrhythmia

研究组 & 干预措施

Patients undergoing primary hip or knee arthroplasty

Patients undergoing primary hip or knee arthroplasty

干预措施: Morphine (Drug)

结局指标

主要结局

Incidence of orthostatic hypotension

时间窗: 30 minutes after morphine administration

Orthostatic hypotension is defined as a fall in systolic pressure \> 20 mmHg and/or diastolic pressure \> 10 mmHg during mobilization

次要结局

  • Changes in cardiac output (CO) during mobilization(Before and 30 minutes after morphine administration)
  • Changes in mean arterial pressure (MAP) during mobilization(Before and 30 minutes after morphine administration)
  • Changes in systemic vascular resistance (SVR) during mobilization(Before and 30 minutes after morphine administration)
  • Changes in cerebral perfusion (ScO2) during mobilization(Before and 30 minutes after morphine administration)
  • Changes in heart rate variability (HRV) during Valsalva manoeuvre(Before and 30 minutes after morphine administration)
  • Changes in systolic arterial pressure (SAP) during mobilization(Before and 30 minutes after morphine administration)
  • Changes in peripheral perfusion index (PPI) during mobilization(Before and 30 minutes after morphine administration)
  • Changes in baroreflex sensitivity - vagal (BRSv) during Valsalva manoeuvre(Before and 30 minutes after morphine administration)
  • Changes in heart rate (HR) during mobilization(Before and 30 minutes after morphine administration)
  • Changes in diastolic arterial pressure (DAP) during mobilization(Before and 30 minutes after morphine administration)
  • Changes in stroke volume (SV) during mobilization(Before and 30 minutes after morphine administration)
  • Changes in muscular perfusion (SmO2) during mobilization(Before and 30 minutes after morphine administration)

研究者

发起方
Copenhagen University Hospital, Hvidovre
申办方类型
Other
责任方
Principal Investigator
主要研究者

Bodil Uldall-Hansen

Research assistant

Copenhagen University Hospital, Hvidovre

研究点 (1)

Loading locations...

相似试验